8-K ·Filed Apr 10, 2026
8-K context-dependent: Items 7.01
Actionable Insight • Neutral
Monitor for future financial updates or milestones related to the withZeta.ai platform, as this disclosure provides no immediate financial data.
Final — all horizons settled through T+60d
LTRN ▲ +81.22% at T+60d
NEUTRAL call +81.22% · α vs SPY +70.89% · entry $1.97 → $3.57
T+1d
+12.69%
call +12.69% · α +11.71%
$2.22
settled 7mo ago
T+5d
+26.40%
call +26.40% · α +21.89%
$2.49
settled 6mo ago
T+20d
+3.55%
call +3.55% · α -4.97%
$2.04
settled 6mo ago
T+60d
+81.22%
call +81.22% · α +70.89%
$3.57
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Lantern Pharma demonstrated its withZeta.ai AI platform, discussing its capabilities, market opportunity, and revenue strategy. This is a forward-looking disclosure with no financial data.
Key Facts
- Company demonstrated its withZeta.ai AI platform
- Presentation covered platform capabilities, rare cancer market opportunity, and revenue strategy
- No financial data or specific metrics were disclosed
- This is a Regulation FD disclosure of forward-looking statements
Financial Impact
No financial impact disclosed
Risk Factors
- Forward-looking statements are subject to risks including funding, research success, partnerships, and market adoption
- No specific financial guidance or metrics were provided
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-016047 |
| Document: 0001493152-26-016047-index-headers.html | 0001493152-26-016047 |
| Document: 0001493152-26-016047-index.html | 0001493152-26-016047 |
| Document: 0001493152-26-016047.txt | 0001493152-26-016047 |
15 reports for LTRN
60% Hit rate @ T+60 Went positive at some point 6 of 9 best @ T+60▲ +56.19%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | DEF 14A | $0.6564 | awaiting T+60 | — | $0.6240 (+4.94%) |
Oct 13, 2026 13d ago | SC 13G/A | $0.7107 | awaiting T+60 | — | $0.6240 (−12.20%) |
Oct 1, 2026 25d ago | 8-K | $0.8601 | awaiting T+60 | — | $0.6240 (+27.45%) |
Sep 30, 2026 26d ago | 8-K | $1.00 | awaiting T+60 | — | $0.6240 (+37.60%) |
Sep 30, 2026 26d ago | 424B5 | $1.01 | awaiting T+60 | — | $0.6240 (+38.22%) |
Sep 23, 2026 4w ago | 8-K | $1.21 | awaiting T+60 | — | $0.6240 (−48.43%) |
Sep 23, 2026 4w ago | 8-K | $1.39 | awaiting T+60 | — | $0.6240 (−55.11%) |
Aug 14, 2026 10w ago | 8-K | $2.65 | awaiting T+60 | — | $0.6240 (−76.45%) |
Jun 22, 2026 18w ago | EFFECT | $3.88 $1.70 | ▲ +56.19% | ▲ +57.93% | $0.6240 (+83.92%) |
May 15, 2026 23w ago | 8-K | $3.00 $2.66 | ▼ −11.33% | ▼ −16.18% | $0.6240 (−79.20%) |
Showing 10 of 15
US Market Status
Market Closed — Opens in 4h 33m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers